JB

Joško Bobanović

at Sofinnova Partners

Paris, Île-de-France

Invests in

Stages:

  • Min Investment:

    $10,000,000.00
  • Max Investment:

    $50,000,000.00
  • Target Investment:

    $25,000,000.00

Skills

investments
private equity
venture capital
M&A experience
Cleantech
Marketing Strategy
Strategic Planning
Internet
Energy Efficiency
Investments
Venture Capital
Mergers
Strategy
Private Equity
Entrepreneurship

Education

Work Experience

  • Partner, Industrial Biotechnology

    2010

    Partnering with exceptional entrepreneurs to deliver sustainable solutions in food, ag, chemicals and materials powered by biotechnology.

  • Board Member

    2022

    Prometheus Materials delivers sustainable building materials that accelerate the world’s transition to a carbon-negative future. Inspired by biological processes found in nature, the company has developed a technology that uses naturally occurring microalgae to produce a bio-cement that offers an affordable, strong, and durable alternative to carbon-intensive portland cement. When mixed with aggregate, this bio-cement creates a zero-carbon building material with the mechanical, physical, and thermal properties comparable or, in some cases, superior to portland cement-based concrete.

  • Board Member

    2020

    Protera makes safe, sustainable, and affordable protein-based food ingredients that address today’s ethical, environmental, and consumer health challenges using proprietary deep learning (AI/ML) algorithm, to predict high value protein products and enzymes with unprecedented speed.

  • Director Board Of Directors

    2019

    DMC is leading the low cost sustainable transformation of multiple product markets. Our novel, patent-pending technology for rapid engineering of robust microbial hosts enables the production of a broad diversity of specialty chemicals, flavors, fragrances, nutraceuticals, natural products, pharmaceuticals, and APIs. Deployment of our Dynamic Metabolic Control technology dramatically reduces the cost and development timeline from discovery to commercial performance. Our ultra low cost development will democratize metabolic engineering efforts, creating a multitude of commercially viable bio-processes and delivering sustainable routes to both new and existing products.

  • Director Board Of Directors

    2018

    Pyrowave is a pioneer of the Plastic-to-Plastic microwave-based chemical recycling technology that allows post-consumer and post-industrial plastics to be regenerated and restored to their full value. Its patented high-power microwave catalytic depolymerization technology platform is the most advanced worldwide and is now at the forefront of the new generation of plastics. By bringing plastics back to their molecular state identical to virgin materials, Pyrowave technology allows infinite recycling of plastics.

  • Board Director

    2018

    Biosyntia is an industrial biotech company developing bio-based manufacturing processes with core capabilities within strain engineering and fermentation. The company was founded in 2012 by Hans Genee, Andreas Lausten and serial entrepreneur, DTU Professor Morten Sommer. Today, 15 scientists and business developers operate from Biosyntia’s lab and offices in Copenhagen, Denmark. Biosyntia develops microbes and processes at an unprecedented speed and efficiency by employing its Biosynthetic Selections™ technology which dramatically reduce the risk, cost and time for developing fermentation processes.

  • Board Director

    2016

    DNA Script is focused on the manufacturing of synthetic DNA using a proprietary template-free enzymatic technology. The company aims at accelerating innovation in life science and technology through rapid, affordable and high quality DNA synthesis.DNA Script's technology has the potential to greatly accelerate the development of new therapeutics, sustainable chemical production, improved crops as well as new applications such as data storage.

Metgen

2012

  • Board Director

    2012

    MetGen is a Finnish company that develops disruptive enzymatic products that enable significant efficiency improvements in the pulp and paper and biochemicals and biofuels industries, as well as removal of toxic micro-pollutants from waste water. The company offers enzymatic solutions for the pre-treatment of a variety of ligno-cellulosic biomass. MetGen provides enzymes that dramatically save energy at the refining step in the pulp and paper industry. In the advanced biofuel sector, MetGen enables production of low cost ligno-cellulosic sugars. MetGen's competitive advantage is the ability to tailor or adapt enzymes to meet each customer’s segment specific needs. www.metgen.com

Comet Bio, Inc.

2015 - 2024

  • Board Director

    2015 - 2024

    Comet Biorefining has developed a novel process to convert cellulosic biomass (wood, straw, corn stover, bagasse) into high quality cost-competitive cellulosic glucose and hemicellulose. This enabling and ground breaking technology allows for production of highly sustainable ingredients for food, feed, biochemicals and biofuels industries.

2013 - 2021

  • Board Director

    2013 - 2021

    Life sciences R&D cloud, enabling life science the way it should be done!